Boston Blog

Tracking Boston research at the ongoing heart meeting

CardioBrief offers reliable reporting from the American Heart Association meeting.

This morning’s tweet @cardiobrief:

One thought about MI FREEE: We can’t even give away life-saving drugs away for free!

Here is the report on medication compliance and free samples released today from

Brigham and Women’s Hospital. From the NEJM publication:

In conclusion, in this randomized trial, the elimination of patient copayments for secondary prevention after myocardial infarction did not significantly reduce rates of the composite primary outcome. We did observe beneficial effects on secondary clinical outcomes, including rates of total major vascular events or revascularization procedures, as well as on rates of first major vascular events and patients’ out-of-pocket spending. The intervention did not change overall health spending. This simple strategy may contribute to ongoing efforts to improve the quality of care for patients after myocardial infarction.

Also out of Boston:

Although medically ill patients remain at risk for VTE after hospital discharge, a strategy of extended oral anticoagulation with apixaban did not prove successful in the ADOPT (Apixaban Dosing to Optimize Protection from Thrombosis) trial, which was presented by Samuel Z Goldhaber at the American Heart Association and published simultaneously in the New England Journal of Medicine.

Comments

Comments are closed.